About
Green tea is derived from the unfermented leaves of Camellia sinensis, preserving high levels of polyphenolic catechins—primarily epigallocatechin-3-gallate (EGCG)—and is used globally as a beverage, natural flavouring, antioxidant, and concentrated food supplement ingredient. It is distinct from black and oolong teas in that it undergoes no fermentation, retaining higher catechin content.
Safety summary
Traditional green tea infusions are generally considered safe at habitually consumed levels (mean EGCG 90–300 mg/day in adults). However, concentrated food supplements providing ≥800 mg EGCG/day have been shown in clinical trials to induce statistically significant increases in serum liver enzymes, and rare idiosyncratic hepatotoxicity cases have been reported even below this dose. Green tea also contains naturally occurring caffeine, requiring caution in pregnant women, infants, children, and caffeine-sensitive individuals.
Regulatory landscape
| Jurisdiction | Status | Note |
|---|---|---|
| EFSA (European Food Safety Authority) (European Union) | Restricted | Commission Regulation (EU) 2022/2340, adopted 30 November 2022 under Article 8 of Regulation (EC) No 1925/2006, mandates EGCG content labelling per serving on all green tea food supplements; EFSA concluded ≥800 mg EGCG/day from supplements may cause liver damage. Traditional infusions prepared in a conventional manner are considered generally safe. C. sinensis is listed in the EFSA Compendium of Botanicals of possible concern.source |
| FSSAI (Food Safety and Standards Authority of India) (India) | Approved | Regulated under FSS (Food Product Standards and Food Additives) Regulations, 2011, Chapter 2.10 (Beverages). Green Tea must be exclusively derived from Camellia sinensis (L.) O. Kuntze, free from added colouring matter and harmful substances; natural flavours permitted with label declaration. Specific health benefit claims require prior FSSAI approval under FSS (Health Supplements, Nutraceuticals) Regulations.source |
| FDA (Food and Drug Administration) (United States) | Approved | Green tea extract is GRAS for use as an antioxidant and flavouring in foods (GRAS notices GRN-225, GRN-259, GRN-772); no specific maximum daily intake established for traditional infusion use. The intended use as an antioxidant is not subject to premarket approval under section 409 of the FD&C Act.source |
Who should approach with care
Research citations
- 1FDA. GRAS Notice GRN No. 259 — Catechins from Green Tea Extract. hfpappexternal.fda.gov
- 2other. Statement on the Hepatotoxicity of Green Tea Catechins: Lay Summary — UK Committee on Toxicity (COT), 2024. cot.food.gov.uk
- 3other. Commission Regulation (EU) 2022/2340 of 30 November 2022 amending Regulation (EC) No 1925/2006 as regards green tea catechins, 2022. eur-lex.europa.eu
- 4EFSA. Scientific Opinion on the safety of green tea catechins, 2018. efsa.europa.eu
- 5FSSAI. Food Safety and Standards (Food Product Standards and Food Additives) Regulations, 2011 — Chapter 2.10: Beverages (Tea), 2011. fssai.gov.in
